Skip to main content
. Author manuscript; available in PMC: 2007 Oct 23.
Published in final edited form as: Pharm Res. 2005 Sep 22;22(10):1700–1707. doi: 10.1007/s11095-005-6335-8

Fig. 6.

Fig. 6

Lung deposition efficiency of nebulized formulation #27 in a human lung replica. Protein concentrations represented are the results of triplicate determinations of formulation nebulized into three separate lung casts. The “Below 4th Generation” section (comprising cast sections T1–5 and B1–5) showed a protein deposition of 4.5 ± 0.19 mg yielding a lower airway deposition of 45%.